Sign in with Google. Opens in new tab
ENTITY
Divi's Laboratories

Divi's Laboratories (DIVI IN)

99
Analysis
Health CareIndia
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
bullishHDFC Bank
30 Jul 2024 07:32

India: Potential Free Float Changes & Passive Flows in August

Changes to shareholding patterns could lead to changes in float for some stocks in local/global indices. Passive trackers will need to trade over 4...

Logo
609 Views
Share
30 Jul 2024 00:10

NIFTY100 Low Volatility 30 Index Rebalance Preview: Four Changes in September

Four constituent changes, volatility changes and capping changes will result in one-way turnover of 16% resulting in a one-way trade of INR 6.71bn...

Logo
395 Views
Share
bullishJSW Energy Ltd
28 Jul 2024 23:09

NIFTY NEXT50 Index Rebalance Preview: 7 Changes as Non-F&O Stocks Replace F&O Members

There could be 7 changes for the Nifty Next 50. The addition of non-FnO stocks and deletion of FnO stocks raises index replication issues. Expect...

Logo
421 Views
Share
26 Jul 2024 14:17

Akums Drugs and Pharmaceuticals IPO: Subscribe on Favorable Industry Tailwind and Reasonable Pricing

Akums Drugs and Pharmaceuticals, has set IPO price band at Rs 646–679 per share, seeking a P/E valuation of 28.7–30.2x, which seems to be...

Logo
585 Views
Share
26 Jul 2024 05:00

Akums Drugs and Pharmaceuticals IPO - RHP Updates & Quick Thoughts on Peer Comp and Valuation

Akums Drugs and Pharmaceuticals is looking to raise up to US$222m in its upcoming India IPO. In this note, we talk about its RHP updates and share...

Logo
Ethan Aw
481 Views
Share
x